NCT00054431 2013-01-23Imatinib Mesylate and Decitabine in Treating Patients With Chronic Myelogenous LeukemiaNational Cancer Institute (NCI)Phase 2 Completed80 enrolled
NCT00101088 2013-01-14Temsirolimus and Imatinib Mesylate in Treating Patients With Chronic Myelogenous LeukemiaNational Cancer Institute (NCI)Phase 1 Terminated21 enrolled